Difficulty: Medium
Average Score: 93%
Practice
Selective estrogen receptor modifiers (SERMs) treat osteoporosis by selectively:
Correct answer
D
Rationale
SERMs (e.g., raloxifene) treat osteoporosis by acting on estrogen receptors in bone, mimicking estrogen's inhibition of osteoclasts, reducing bone resorption by 2-3% annually (MORE trial). Magnesium resorption isn't affected SERMs target bone, not kidneys. Calcium absorption is vitamin D's role, not SERMs'. Inhibiting osteoblasts would worsen osteoporosis SERMs suppress osteoclasts. Receptor-specific action, per FDA approval data, makes D the precise choice.